IDiyas

For the Inventor, By the Inventor

Larchmont, NY, United States of America

Carl F Nathan

USPTO Granted Patents = 23 

 

Average Co-Inventor Count = 3.5

ph-index = 7

Forward Citations = 148(Granted Patents)


Company Filing History:

goldMedal11 out of 1,360 
 
Cornell University
 patents
silverMedal9 out of 1,521 
 
Cornell Research Foundation Inc.
 patents
bronzeMedal3 out of 8 
 
Tri-institutional Therapeutics Discovery Institute
 patents
4. 2 out of 712 
 
The Rockefeller University
 patents
5. 2 out of 4,770 
 
Merck + Co., Inc.
 patents
6. 1 out of 547 
 
University of Kansas-ku Medical Center Research Institute
 patents
7. 1 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1992-2025

Loading Chart...
Loading Chart...
23 patents (USPTO):
1. 12473331 - Macrocyclic compounds as proteasome inhibitors (2025-11-18),
2. 12016896 - Dipeptidomimetics as inhibitors of human immunoproteasomes (2024-06-25),
3. RE49816 - Dipeptides as inhibitors of human immunoproteasomes (2024-01-30),
4. 11834515 - Macrocyclic compounds as proteasome inhibitors (2023-12-05),
5. 11732005 - Peptidomimetic proteasome inhibitors (2023-08-22),
6. 11629141 - Proteasome inhibitors and uses thereof (2023-04-18),
7. 11203613 - Peptidomimetic proteasome inhibitors (2021-12-21),
8. 11202817 - Dipeptidomimetics as inhibitors of human immunoproteasomes (2021-12-21),
9. 11066397 - Proteasome inhibitors and uses thereof (2021-07-20),
10. 10059722 - Cephalosporin derivatives and methods of use (2018-08-28),
11. 9988421 - Dipeptides as inhibitors of human immunoproteasomes (2018-06-05),
12. 8951992 - [object Object] (2015-02-10),
13. 8338465 - Cyclic carboxylic acid rhodanine derivatives for the treatment and prevention of tuberculosis (2012-12-25),
14. 7977366 - Treating an inflammatory disorder or inhibiting respiratory burst in adherent neutrophils with chemical inhibitors of neutrophil activation (2011-07-12),
15. 7427595 - Use of proepithelin to promote wound repair and reduce inflammation (2008-09-23),

Title: Unveiling the Innovations of Inventor Carl F Nathan

Introduction: Inventor Carl F Nathan, hailing from Larchmont, NY, has made significant contributions to the field of medicine and pharmaceuticals with a remarkable portfolio of 20 patents under his belt.

Latest Patents: Among his latest patents are groundbreaking inventions in the form of macrocyclic compounds as proteasome inhibitors and peptidomimetic proteasome inhibitors. These compounds hold promise in treating a wide array of conditions ranging from bacterial and parasite infections to cancer, autoimmune disorders, and neurodegenerative diseases.

Career Highlights: Carl F Nathan has left an indelible mark on the industry through his work at esteemed institutions like Cornell Research Foundation Inc. and Cornell University. His dedication to advancing medical research has led to the development of innovative solutions that have the potential to transform healthcare as we know it.

Collaborations: Throughout his career, Carl F Nathan has collaborated with esteemed professionals in the field, including coworkers Gang Herbert Lin and Joelle E Gabay. These collaborations have been instrumental in pushing the boundaries of scientific discovery and driving forward groundbreaking research initiatives.

Conclusion: In conclusion, Carl F Nathan's innovative spirit and unwavering dedication to scientific advancement have cemented his legacy as a trailblazer in the field of pharmaceuticals. His groundbreaking patents stand as a testament to his insatiable drive to make a tangible impact on the world of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…